EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review

Louis de Courcy, Jack Moore

Clinical Cardiology · 2026-11 · 49 (11)

DOI: 10.1002/clc.70519 ↗

At a glance

Systematische Übersicht in Clinical Cardiology, published online on 2026-11-17. Written by Louis de Courcy and 1 co-authors. 50 references. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

Pro‐inflammatory cytokines play an important role in multiple facets of coronary artery disease (CAD), from endothelial dysfunction to plaque development and rupture to reperfusion injury post‐revascularisation. We aimed to identify and present key data from randomized controlled trials (RCTs) which investigate anti‐inflammatory drugs with the goal of improving outcomes associated with CAD. Methods and Results We searched for placebo‐controlled RCTs across three databases (Cochrane Library, PubMed, and ClinicalTrials.gov ) using the terms “anti‐inflammatory” and “coronary artery disease” as well as variants. Thirty‐three studies were identified and categorized as: (a) secondary prevention of major adverse cardiovascular events (MACE), (b) secondary prevention of radiographic evidence of CAD, and (c) reduction in reperfusion injury when administered during reperfusion. Seven trials demonstrated a reduction in CAD, including five phase III trials for secondary prevention of MACE.

Conclusion

The majority of anti‐inflammatory therapies did not show improved outcomes across a variety of endpoints. However colchicine and canakinumab have shown benefit in reducing MACE in phase III trials, while tocilizumab improved myocardial salvage index when administered peri‐reperfusion. These findings suggest that the NLRP3–IL1β–IL6–CRP pathway may represent a promising therapeutic target and an important focus for future research in CAD prevention, particularly in patients with high residual inflammatory risk.

Cite

APA

Courcy, L. D., & Moore, J. (2026). Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70519

Vancouver

Courcy LD, Moore J. Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70519

BibTeX
@article{Courcy2026,
  author = {Courcy, Louis de and Moore, Jack},
  title = {Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {11},
  doi = {10.1002/clc.70519}
}
Start for free →